Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00862641

Public ClinicalTrials.gov record NCT00862641. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease (COPD).

Study identification

NCT ID
NCT00862641
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
1,009 participants

Conditions and interventions

Interventions

  • Regadenoson Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2009
Primary completion
Sep 30, 2009
Completion
Sep 30, 2009
Last update posted
Sep 17, 2012

2009

United States locations

U.S. sites
48
U.S. states
25
U.S. cities
46
Facility City State ZIP Site status
Not listed Montgomery Alabama 36117
Not listed Anaheim California 92801
Not listed Encinitas California 92024
Not listed Fullerton California 92835
Not listed Huntington Beach California 92647
Not listed Long Beach California 90806
Not listed Mission Viejo California 92691
Not listed Roseville California 95661
Not listed San Diego California 92120
Not listed San Diego California 92123
Not listed Santa Ana California 92704
Not listed Waterbury Connecticut 06708
Not listed Newark Delaware 19713
Not listed Wilmington Delaware 19807
Not listed Clearwater Florida 33756
Not listed DeLand Florida 32720
Not listed Miami Florida 33173
Not listed Trinity Florida 34655
Not listed Winter Park Florida 32789
Not listed Stockbridge Georgia 30281
Not listed Aurora Illinois 60504
Not listed Topeka Kansas 66606
Not listed Shreveport Louisiana 71104
Not listed Auburn Maine 04210
Not listed No. Dartmouth Massachusetts 02747
Not listed Minneapolis Minnesota 55402
Not listed Plymouth Minnesota 55441
Not listed St Louis Missouri 63141
Not listed Papillion Nebraska 68046
Not listed Brick New Jersey 08723
Not listed Raleigh North Carolina 27607
Not listed Chardon Ohio 44024
Not listed Cincinnati Ohio 45206
Not listed Cincinnati Ohio 45231
Not listed Oklahoma City Oklahoma 73103
Not listed Medford Oregon 97504
Not listed Upland Pennsylvania 19013
Not listed Providence Rhode Island 02906
Not listed Charleston South Carolina 29407
Not listed Easley South Carolina 29640
Not listed Greenville South Carolina 29615
Not listed Spartanburg South Carolina 29303
Not listed Knoxville Tennessee 37920
Not listed Dallas Texas 75231
Not listed Houston Texas 77074
Not listed New Braunfels Texas 78130
Not listed San Antonio Texas 78229
Not listed Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00862641, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 17, 2012 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00862641 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →